CVS Group (LON:CVSG) Shares Pass Above 200 Day Moving Average – Here’s Why

CVS Group plc (LON:CVSG) shares passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 1,264.43 and traded as high as GBX 1,356. CVS Group shares last traded at GBX 1,346, with a volume of 367,309 shares traded.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on CVSG shares. Royal Bank Of Canada lifted their price target on shares of CVS Group from GBX 1,500 to GBX 1,900 and gave the company an “outperform” rating in a research report on Tuesday, October 21st. Peel Hunt reiterated a “buy” rating and issued a GBX 1,600 target price on shares of CVS Group in a report on Tuesday, November 18th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of CVS Group from GBX 1,500 to GBX 1,700 and gave the stock a “buy” rating in a research report on Tuesday, October 21st. Jefferies Financial Group raised their price target on CVS Group from GBX 1,250 to GBX 1,420 and gave the company a “hold” rating in a research report on Wednesday, October 22nd. Finally, Berenberg Bank reiterated a “buy” rating and issued a GBX 2,000 price objective on shares of CVS Group in a research note on Tuesday, November 18th. Four analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of GBX 1,724.

CVS Group Trading Down 0.9%

The company has a 50 day moving average of GBX 1,289.89 and a 200 day moving average of GBX 1,264.43. The firm has a market cap of £951.32 million, a price-to-earnings ratio of 18.42, a price-to-earnings-growth ratio of 1.77 and a beta of 1.02. The company has a current ratio of 1.09, a quick ratio of 0.90 and a debt-to-equity ratio of 110.52.

Insider Activity

In other CVS Group news, insider Robin Alfonso acquired 870 shares of CVS Group stock in a transaction on Monday, November 17th. The shares were bought at an average price of GBX 1,147 per share, with a total value of £9,978.90. Also, insider Paul Higgs bought 1,235 shares of the firm’s stock in a transaction dated Friday, December 5th. The shares were acquired at an average price of GBX 1,214 per share, for a total transaction of £14,992.90. In the last three months, insiders purchased 7,430 shares of company stock valued at $261,935,755. Corporate insiders own 1.42% of the company’s stock.

CVS Group Company Profile

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.